Literature DB >> 1913493

Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases.

D Civalleri1, M Esposito, R A Fulco, M Vannozzi, N Balletto, F De Cian, F DeCian, P L Percivale, F Merlo.   

Abstract

Arterial chemoembolization of liver tumors should improve regional treatment by reducing native blood flow of the whole organ and redistributing residual flow toward hypovascular masses. Plasma cisplatin pharmacokinetics and its tissue uptake and relative tumor and liver vascularity were studied during surgical placement of arterial catheters in four patients and in four patients with colorectal metastases given intraoperative arterial cisplatin (DDP, 25 mg/m2), with an without coadministration of 600 mg degradable starch microspheres (DSM). Mean (+/- standard deviation) filterable plasma platinum levels peaked later (2 minutes) and were significantly lower after DDP with DSM (1.23 +/- 0.69 micrograms/ml) than after DDP alone (2.13 +/- 0.43 micrograms/ml, P less than 0.05), with the area under the curve (AUC0-30 min) values of 15.8 +/- 5.5 and 25.1 +/- 3.8 micrograms x min/ml (P less than 0.05), respectively. No differences in urine excretion, total body clearance, or plasma protein binding of platinum were observed. Tissue biopsies were started 15 minutes after DDP administration and completed in all cases within 5 minutes. Tumor platinum concentrations were significantly higher after DDP with DSM (3.03 +/- 1.60 micrograms/g) than after DDP alone (0.67 +/- 0.49 micrograms/ml, P less than 0.05). Liver concentrations and tumor-liver ratios of platinum also were higher, although not significantly, after DDP with DSM. Preoperative vascularization, studied with arterial perfusion scan, influenced individual tissue drug uptake in cases given DDP alone, with the lowest tumor levels in cold masses. Very high and almost superimposable liver and tumor concentrations were measured in those receiving DDP and DSM. The latter phenomenon was irrespective of native vascularization, indicating that DSM administration induced both an increased whole-liver extraction of the drug and a redistribution of blood flow and flow-dependent tissue uptake of platinum.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913493     DOI: 10.1002/1097-0142(19910901)68:5<988::aid-cncr2820680513>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  [Experimental research about effectiveness of transarterial chemoembolization (TACE) in an animal model of hepatocellular carcinoma].

Authors:  J Qian; G Feng; L Trübenbach; P L Pereira; P E Huppert; C D Claussen
Journal:  J Tongji Med Univ       Date:  2001

2.  Pharmaceuticals for Intra-arterial Therapy.

Authors:  Aalpen A Patel; Jeffery A Solomon; Michael C Soulen
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

3.  Combination treatment of CC531-lac-Z rat liver metastases by chemoembolization with pemetrexed disodium and gemcitabine.

Authors:  Michael Rodenbach; Ergül Eyol; Matthias H Seelig; Martin R Berger
Journal:  J Cancer Res Clin Oncol       Date:  2005-01-19       Impact factor: 4.553

4.  Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization.

Authors:  Germano Scevola; Giorgio Loreni; Marco Rastelli; Stefano Sposato; Sara Ramponi; Vittorio Miele
Journal:  Med Oncol       Date:  2017-02-03       Impact factor: 3.064

Review 5.  Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres.

Authors:  T Taguchi
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

6.  Chemoembolization of rat liver metastasis with irinotecan and quantification of tumor cell reduction.

Authors:  Jan Saenger; Maike Leible; Matthias H Seelig; Martin R Berger
Journal:  J Cancer Res Clin Oncol       Date:  2004-01-22       Impact factor: 4.553

Review 7.  Clinical pharmacokinetic advantages of new drug delivery methods for the treatment of liver tumours.

Authors:  J H Anderson; H W Warren; C S McArdle
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

8.  Mapping Drug Dose Distribution on CT Images Following Transarterial Chemoembolization with Radiopaque Drug-Eluting Beads in a Rabbit Tumor Model.

Authors:  Andrew S Mikhail; William F Pritchard; Ayele H Negussie; Venkatesh P Krishnasamy; Daniel B Amchin; John G Thompson; Paul G Wakim; David Woods; Ivane Bakhutashvili; Juan A Esparza-Trujillo; John W Karanian; Sean L Willis; Andrew L Lewis; Elliot B Levy; Bradford J Wood
Journal:  Radiology       Date:  2018-08-14       Impact factor: 11.105

9.  Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.

Authors:  Robert Cg Martin; Ken Robbins; Dana Tomalty; Ryan O'Hara; Petar Bosnjakovic; Radek Padr; Miloslav Rocek; Frantisek Slauf; Alexander Scupchenko; Cliff Tatum
Journal:  World J Surg Oncol       Date:  2009-11-03       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.